| http://www.w3.org/ns/prov#value | - In contrast, in phase 2 there was an improvement in left ventricular ejection fraction (from 27.1??6.6% to 34.9??10.9%; P=0.001), increase in 6-minute walk distance (from 411??116 to 496??113 m; P=0.001), and a decrease in N-terminal pro B-type natriuretic peptide (from 3672??5165 to 1488??1847 pg/mL; P=0.04).
|
